NCT00726700View on ClinicalTrials.gov

Pegfilgrastim and Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Aggressive B-Cell Non-Hodgkin Lymphoma

PHASE2CompletedINTERVENTIONAL

Enrollment

109

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions

Lymphoma

Interventions

BIOLOGICAL

pegfilgrastim

Given subcutaneously

BIOLOGICAL

rituximab

Given IV

DRUG

cyclophosphamide

Given IV

DRUG

doxorubicin hydrochloride

Given IV

DRUG

prednisone

Given orally

DRUG

vincristine sulfate

Given IV

All Listed Sponsors

lead

Universität des Saarlandes

OTHER

NCT00726700 - Pegfilgrastim and Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Aggressive B-Cell Non-Hodgkin Lymphoma | Biotech Hunter | Biotech Hunter